Instil Bio, Inc.
NASDAQ:TIL
19.09 (USD) • At close December 31, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Instil Bio, Inc. |
Symbool | TIL |
Munteenheid | USD |
Prijs | 19.09 |
Beurswaarde | 124,579,240 |
Dividendpercentage | 0% |
52-weken bereik | 7.28 - 92 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Bronson Crouch |
Website | https://instilbio.com |
An error occurred while fetching data.
Over Instil Bio, Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)